Date: 11.6.2021
Summary:
A research group based in Italy has developed a new class of small molecules acting as SERPINA3 inhibitors, which are able to reduce prion protein (PrPSc) accumulation in prion-infected cell lines, thereby representing a new therapeutic treatment against prion and prion-like diseases. They are looking for licence agreements and joint venture agreements with pharma companies and/or financial agreements with investors.
Reference: TOIT20210421001
Country: Italy
Submitted: 6. 11. 2021
Keywords
Technology: Neurology, Brain Research.
Market: Drug delivery and other equipment.
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Books - Huge database of biotechnology books
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
Gene-edited pig kidney transplanted into first living human patient
New class of antimicrobials discovered in soil bacteria